Various studies, though not population-based studies, indicated that the inclusion of mpMRI after a positive PSA test followed by MRI-guided biopsy is cost-effective compared to a regular prostate cancer screening pathway34–36. This evidence concerns the gene KLK3 and prostate carcinoma.